- Home
- DSM vs OSUR Comparison
DSM vs OSUR Comparison
Compare DSM & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSM
- OSUR
- Stock Information
- Founded
- DSM 1989
- OSUR 2000
- Country
- DSM United States
- OSUR United States
- Employees
- DSM N/A
- OSUR N/A
- Industry
- DSM Investment Managers
- OSUR Medical/Dental Instruments
- Sector
- DSM Finance
- OSUR Health Care
- Exchange
- DSM Nasdaq
- OSUR Nasdaq
- Market Cap
- DSM 301.0M
- OSUR 289.4M
- IPO Year
- DSM N/A
- OSUR 1986
- Fundamental
- Price
- DSM $5.77
- OSUR $3.64
- Analyst Decision
- DSM
- OSUR Hold
- Analyst Count
- DSM 0
- OSUR 2
- Target Price
- DSM N/A
- OSUR $5.50
- AVG Volume (30 Days)
- DSM 161.7K
- OSUR 1.0M
- Earning Date
- DSM 01-01-0001
- OSUR 11-06-2024
- Dividend Yield
- DSM 3.97%
- OSUR N/A
- EPS Growth
- DSM N/A
- OSUR N/A
- EPS
- DSM N/A
- OSUR 0.15
- Revenue
- DSM N/A
- OSUR $224,263,000.00
- Revenue This Year
- DSM N/A
- OSUR N/A
- Revenue Next Year
- DSM N/A
- OSUR N/A
- P/E Ratio
- DSM N/A
- OSUR $24.13
- Revenue Growth
- DSM N/A
- OSUR N/A
- 52 Week Low
- DSM $4.69
- OSUR $3.58
- 52 Week High
- DSM $6.05
- OSUR $8.45
- Technical
- Relative Strength Index (RSI)
- DSM 28.05
- OSUR 39.12
- Support Level
- DSM $5.76
- OSUR $3.76
- Resistance Level
- DSM $6.18
- OSUR $3.70
- Average True Range (ATR)
- DSM 0.05
- OSUR 0.17
- MACD
- DSM -0.03
- OSUR -0.02
- Stochastic Oscillator
- DSM 8.33
- OSUR 10.00
About DSM BNY Mellon Strategic Municipal Bond Fund Inc.
BNY Mellon Strategic Municipal Bond Fund, Inc. is a diversified closed-end management investment company. Its investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.